PillRx only · Tablet, Delayed Release · Oral
Sulfasalazine
Brands: Azulfidine En-Tabs · Sulfasalazine
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers3 labelers
Packages6
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.284
Latest avg · Jun 17, 2026
+6%
Since Dec 17, 2025
3
Active US suppliers
67%
Top-2 supplier share*
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | unknown | 2 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | unknown | 2 | SUPPLYING |
| SUNRISE PHARMACEUTICAL, INC | unknown | 2 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.